Skip over navigation
Banner
Industry
Directory Facilities Technology Transfer Economic Develop. NV BioHistory (TM)
Career
Job Search Post a Job Destination NV
News/Events
Industry News Submit News Release Calendar Submit Event CEO Reading
Patient
Clinical Trials Drug Development Resources
Education
K-12 Higher Ed BioEd Reading
About
Advertising Feedback Home
 
About
 Advertising
 Feedback
 Home
Quick Links
 Directory
 Job Search
 Facilities
 Calendar
 Advertising
Community Service Ad: Athena Partners - Eliminating women's cancers
Events
 
Jobs
 

Earn a UW master’s or certificate in medical engineering or pharmaceutical bioengineering.

ORCA Annual Meeting & Social: Sept. 22 - Save the Date! (PDF 86 kb)


BioHistory Moment: FDA requested help in removing a hazardous product, "X-33 Water Repellent," from the market

German chemist Felix Hoffmann synthesized aspirin and heroin

On August 30, 1964, the FDA asked state and local health and safety officials for help in removing "X-33 Water Repellent" from the market. The extremely flammable product had caused three deaths and more than 30 injuries through flash explosions, in many cases while it was being used in home basements to waterproof masonry.

Federal oversight of consumer products such as X-33 and many other items used in the home was transferred to the newly created Consumer Product Safety Commission in 1973. One class of consumer products still regulated by the FDA is radiation-emitting products.

More...

Learn about Sacramento's Embarcadero Road Biotech/Medical Device Facility

890 Embarcadero Road, West Sacramento, CA. The Embarcadero Road biotech/medical device facility, located just off Riverside Parkway and Interstate 80, ecompasses 425,146 square feet on 9.76 Acres. This unique facility offers office, laboratory, manufacturing, and assembly space, plus cleanrooms to address your every need. This facility is located in a state designated Enterprise Zone, and the West Sacrament Redevelopment Area/Targeted Employment Zone providing additional incentives and benefits for your company.

Learn about biotechnology, medical device and pharmaceutical facilities available for sale, lease or sublease in Nevada, regionally or nationwide.

More...

(Advertising)


Industry News...

    Free News Release Posting & Archiving Service


  • European Commission issues positive decision for approval of Seroquel XR  AstraZeneca announced the European Commission issued a positive decision for the approval of once-daily SEROQUEL XR Extended Release Tablets as an add-on treatment of major depressive episodes in patients with Major Depressive Disorder who had sub-optimal response to antidepressant monotherapy.
    AstraZeneca  September 02, 2010  


  • New England Journal of Medicine reports Xpert MTB/RIF a faster Tuberculosis test  New England Journal of Medicine reports Xpert MTB/RIF a faster, more Cepheid announced that its Xpert(R) MTB/RIF test was the subject of a study published in the latest edition of the New England Journal of Medicine (NEJM), "Rapid Molecular Detection of Tuberculosis and Rifampin Resistance."
    Cepheid  September 02, 2010  


  • Halozyme begins phase 2 clinical trial with insulin analogs Lispro and Aspart with rHuPH20  Halozyme Therapeutics announced the initiation of two Phase 2 Ultrafast Insulin treatment studies that utilize its rHuPH20 hyaluronidase enzyme in combination with the two leading commercially available mealtime analogs: insulin aspart, NovoLog, and insulin lispro, the active ingredient in Humalog.
    Halozyme Therapeutics, Inc.  September 02, 2010  


  • XOMA regains NASDAQ compliance  XOMA announced that NASDAQ has notified the Company that it regained compliance with the minimum $1.00 per share bid price requirement for continued listing. Accordingly, the Company will continue to be listed on The NASDAQ Global Market.
    XOMA Ltd.   September 02, 2010  


  • XOMA regains NASDAQ compliance  XOMA announced that NASDAQ has notified the Company that it regained compliance with the minimum $1.00 per share bid price requirement for continued listing. Accordingly, the Company will continue to be listed on The NASDAQ Global Market.
    XOMA Ltd.   September 02, 2010  


More... | Submit News Release | Advertising...

Novo Nordisk Banner Ad

New Job Postings...

Free Job Posting Trial Offer
  • Head of Medical Affairs Operations  Seattle Genetics, Inc. (WA)
  • Molecular & FISH Technologist CellNetix Pathology and Laboratories  (WA)
  • Postdoctoral Research Associate Benaroya Research Institute (WA)
  • Animal Technician I Benaroya Research Institute (WA)
  • Research Technician I/II Benaroya Research Institute (WA)
More... | Job Advertising... | About Job Postings...
Gilead - Careers for Life

New Facilities Available...

ATC clean room constructors...validation guaranteed!
  • 890 Embarcadero Road Property -- West Sacramento, CA
  • Icogenex Biotech Incubator -- Seattle, WA
  • Biotech and Life Sciences Incubator -- Seattle, WA
  • University of Iowa Oakdale Research Park Biotech Building -- Coralville, IA
  • University of Iowa Oakdale Research Park BioVentures Center -- Coralville, IA
More... | Facility Advertising...
UW Surplus

Upcoming Events...

  • 09/12/2010: 2010 Agricultural Biotechnology International Conference
  • 09/13/2010: The Future of Bio-Based Chemicals – Inception to Marketplace
  • 09/13/2010: SEB Food Security and Safety Symposium
  • 09/13/2010: ADAPT 2010
  • 09/13/2010: Biotechnology: Science for Managers
More... | Submit Event | Event Advertising...
Novo Nordisk Banner Ad

Learn About Nevada's BioHistory

Learn About Nevada's BioHistory Why is there a life science industry in Nevada? Is the industry growing? What do other states have?

Through Nevada BioHistory, you can learn about the scientists, institutions, political leaders, and significant events that have shaped and are still shaping the biotechnology, medical device and life science industry in Nevada.

More...

BioEvolution Posters

WA BioEvolution 2008 Poster

More More...


August: National Immunization Awareness Month

National Immunization Awareness Month

The goal of National Immunization Awareness Month (NIAM) is to increase awareness about immunizations across the life span, from infants to the elderly.

Immunization is one of the most significant public health achievements of the 20th century. Vaccines have eradicated smallpox, eliminated wild poliovirus in the U.S. and significantly reduced the number of cases of measles, diphtheria, rubella, pertussis and other diseases. But despite these efforts, people in the U.S. still die from these and other vaccine-preventable diseases.

More...


BioFact

(1839) - Congress puts $1,000 into the Congressional Seed Distribution Program, administered by the U.S. Patent Office, to increase the amount of free seeds mailed to anyone requesting them.


It's a Small World

  Burkholderia Pseudomallei Burkholderia Pseudomallei  

Science Quote

"One thing I have learned in a long life: that all our science, measured against reality, is primitive and childlike and yet it is the most precious thing we have."

-  Albert Einstein
 (1879-1955)

 
Email thie page to a friend. Email This Page
to a Friend
Print this page. Print This
Page
© 2010 Info.Resource, Inc. All rights reserved.
Privacy Policy . Terms of Use . Advisory Board . Advertising

NevadaLifeSciences.com, owned and published by Info.Resource, Inc., is a resource
for the life science industry in the state of Nevada.